Maryland Area

Neuroendocrine Malignancies: Advanced Targeted Therapy with Lutetium Lu-177 DOTATATE.

Precision Radiation. Targeted to the Cell.

An advanced radiopharmaceutical that binds directly to neuroendocrine tumor cells, delivering therapeutic radiation where it’s needed most — while sparing healthy tissue.

Find Out If You’re a Candidate

Fill out the form to schedule your personalized consultation.
By initiating a form fill, you’re consenting to be contacted with treatment information from United Theranostics.

This field is for validation purposes and should be left unchanged.

This field is hidden when viewing the form

Full Name(Required)

Name(Required)

Email(Required)

Phone(Required)

Best Time To Reach You:(Required)

Select your current status(Required)

Additional Information (Optional)

CAPTCHA

Therapy Designed for Precision

Lutathera® represents a new era in oncology — moving beyond broad-spectrum treatments to deliver radiation with extraordinary accuracy.

Targeted Action

Binds to somatostatin receptors expressed on neuroendocrine tumor cells, concentrating radiation exactly at the site of disease.

Personalized Care

Treatment plans are tailored to each patient’s unique clinical and molecular profile, guided by imaging-confirmed receptor expression.

Outpatient Convenience

Most treatment cycles are performed on an outpatient basis at our specialized facilities — no prolonged hospital stays required.

Proven Efficacy

Demonstrated clinical results in tumor control and symptom relief for patients with advanced or metastatic neuroendocrine tumors.

How Lutathera® Works

From imaging confirmation to ongoing monitoring, every step is designed around accuracy and your wellbeing.

Molecular Imaging

PET or SPECT scans confirm the presence of somatostatin receptor-positive tumors, ensuring you are a strong candidate for therapy.



IV Administration

Lutathera® is administered intravenously in a controlled clinical setting, where it travels through the bloodstream to seek out tumor cells.



Targeted Radiation

The radioactive lutetium binds to receptors on cancer cells and emits beta radiation, destroying tumor cells while limiting exposure to surrounding healthy tissue.



Ongoing Monitoring

Regular follow-up imaging and laboratory work assess your treatment response, allowing your care team to adapt your plan as needed.



Who Can Benefit?

Lutathera® may be right for you if you meet one or more of the following criteria:

Recently diagnosed With Neuroendocrine Tumor
Seeking effective alternatives to chemotherapy or surgery
Not responding adequately to prior systemic treatments
Confirmed somatostatin receptor expression on imaging (PET or SPECT)
Interested in a targeted, outpatient-based treatment approach

Schedule Your Consultation Today

Frequently Asked Questions

Everything you need to know before your first appointment.

What is Lutetium Lu-177 DOTATATE therapy?

Lutathera® is a targeted radiopharmaceutical therapy for patients with neuroendocrine tumors. It binds directly to tumor cells via somatostatin receptors and delivers therapeutic radiation with high precision, minimizing harm to healthy tissue.

Am I eligible for this therapy?

Eligibility is confirmed through PET or SPECT imaging to verify somatostatin receptor expression on your tumors. Our clinical team reviews your full medical history and imaging results to assess candidacy.

What can I expect during treatment?

Treatment is delivered as an outpatient infusion over a short session. Most patients receive several cycles spaced weeks apart. Our team will guide you through every step before, during, and after each cycle.

What are the potential side effects?

Some patients experience mild to moderate side effects such as nausea, fatigue, or temporary changes in blood counts. Our clinical team provides comprehensive support throughout your treatment to manage any adverse effects.

How soon can I start treatment?

After your initial consultation and eligibility assessment, therapy can begin promptly.

Will my insurance cover this therapy?

United Theranostics assists patients with insurance verification and can help identify financial assistance programs for those who qualify.

How do I prepare for my appointment?

Our team will provide clear, detailed instructions before each treatment session, including any dietary restrictions, medication considerations, and what to bring on the day of your visit.

What follow-up care is required?

Regular follow-up visits with imaging and lab tests are recommended after your treatment cycles to monitor your response and ensure your care plan is optimally adjusted over time.

Ready to Explore Targeted Therapy?

If you or a loved one has been diagnosed with a neuroendocrine tumor, reach out today to find out if Lutathera® therapy is right for you.

Don’t wait—your next chapter could start today.

👉 Schedule Your Consultation Now